Literature DB >> 26547793

Validation of sun exposure and protection index (SEPI) for estimation of sun habits.

H Detert1, S Hedlund2, C D Anderson3, Y Rodvall4, K Festin5, D C Whiteman6, M Falk7.   

Abstract

BACKGROUND: In both Sweden and Australia high incidence rates of skin cancer have become a major health problem. In prevention and risk communication, it is important to have reliable ways for identifying people with risky sun habits. In this study the validity and reliability of the questionnaire Sun Exposure Protection Index (SEPI), developed to assess individual's sun habits and their propensity to increase sun protection during routine, often brief, clinical encounters, has been evaluated. The aim of our study was to evaluate validity and reliability of the proposed SEPI scoring instrument, in two countries with markedly different ultraviolet radiation environments (Sweden and Australia).
METHOD: Two subpopulations in Sweden and Australia respectively were asked to fill out the SEPI together with the previously evaluated Readiness to Alter Sun Protective Behaviour questionnaire (RASP-B) and the associated Sun-protective Behaviours Questionnaire. To test reliability, the SEPI was again filled out by the subjects one month later.
RESULTS: Comparison between SEPI and the questions in the Sun-protective Behaviours Questionnaire, analyzed with Spearman's Rho, showed good correlations regarding sun habits. Comparison between SEPI and RASP-B regarding propensity to increase sun protection showed concurrently lower SEPI mean scores for action stage, but no difference between precontemplation and contemplation stages. The SEPI test-retest analysis indicated stability over time. Internal consistency of the SEPI, assessed with Cronbach's alpha estimation showed values marginally lower than the desired >0.70 coefficient value generally recommended, and was somewhat negatively affected by the question on sunscreen use, likely related to the classic "sunscreen paradox". There were some differences in the performance of the SEPI between the Swedish and Australian samples, possibly due to the influence of "available" sunlight and differing attitudes to behaviour and protection "at home" and on vacation.
CONCLUSIONS: SEPI appears to be a stable instrument with an overall acceptable validity and reliability, applicable for use in populations exposed to different UVR environments, in order to evaluate individual sun exposure and protection.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Questionnaire; Skin cancer; Sun habits; Sun protection; Ultraviolet exposure

Mesh:

Substances:

Year:  2015        PMID: 26547793     DOI: 10.1016/j.canep.2015.10.022

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  8 in total

1.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

2.  Knowledge and habits of sun exposure in university students: a cross-sectional study in Southern Brazil.

Authors:  Lia Natália Diehl Dallazem; Ana Maria Benvegnú; Juliana Mazzoleni Stramari; André Avelino Costa Beber; Raissa Massaia Londero Chemello; Maristela de Oliveira Beck
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

Review 3.  Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury.

Authors:  Stella P Hartono; Victoria M Bedell; Sk Kayum Alam; Madelyn O'Gorman; MaKayla Serres; Stephanie R Hall; Krishnendu Pal; Rachel A Kudgus; Priyabrata Mukherjee; Davis M Seelig; Alexander Meves; Debabrata Mukhopadhyay; Stephen C Ekker; Luke H Hoeppner
Journal:  Mayo Clin Proc       Date:  2021-11-23       Impact factor: 7.616

4.  A Skin Cancer Prevention Facial-Aging Mobile App for Secondary Schools in Brazil: Appearance-Focused Interventional Study.

Authors:  Titus Josef Brinker; Marlene Heckl; Martina Gatzka; Markus V Heppt; Henrique Resende Rodrigues; Sven Schneider; Wiebke Sondermann; Carolina de Almeida E Silva; Michael C Kirchberger; Joachim Klode; Alexander H Enk; Sarah Knispel; Christof von Kalle; Ingo Stoffels; Dirk Schadendorf; Yasuhiro Nakamura; Stefan Esser; Aisllan Assis; Breno Bernardes-Souza
Journal:  JMIR Mhealth Uhealth       Date:  2018-03-09       Impact factor: 4.773

5.  A skin cancer prevention photoageing intervention for secondary schools in Brazil delivered by medical students: protocol for a randomised controlled trial.

Authors:  Titus Josef Brinker; Bianca Lisa Faria; Martina Gatzka; Olber Moreira de Faria; Markus V Heppt; Michael C Kirchberger; Dirk Schadendorf; Yasuhiro Nakamura; Fabian Buslaff; Oscar Campos Lisboa; Ana Carla Cruz Oliveira; Henrique Augusto Lino; Breno Bernardes-Souza
Journal:  BMJ Open       Date:  2018-03-06       Impact factor: 2.692

6.  Sun Exposure and Protection Index (SEPI) and Self-Estimated Sun Sensitivity.

Authors:  Karin Widemar; Magnus Falk
Journal:  J Prim Prev       Date:  2018-10

7.  Photoaging Mobile Apps in School-Based Melanoma Prevention: Pilot Study.

Authors:  Titus Josef Brinker; Christian Martin Brieske; Christoph Matthias Schaefer; Fabian Buslaff; Martina Gatzka; Maximilian Philip Petri; Wiebke Sondermann; Dirk Schadendorf; Ingo Stoffels; Joachim Klode
Journal:  J Med Internet Res       Date:  2017-09-08       Impact factor: 5.428

8.  Effect of a Face-Aging Mobile App-Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil: A Cluster-Randomized Clinical Trial.

Authors:  Titus J Brinker; Bianca Lisa Faria; Olber Moreira de Faria; Joachim Klode; Dirk Schadendorf; Jochen S Utikal; Ute Mons; Eva Krieghoff-Henning; Oscar Campos Lisboa; Ana Carla Cruz Oliveira; Henrique Augusto Lino; Breno Bernardes-Souza
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.